<DOC>
	<DOCNO>NCT01635400</DOCNO>
	<brief_summary>The purpose study find correlation uridine diphosphate glucuronosyl transferase 1A1 ( UGT1A1 ) gene polymorphisms side effect efficacy irinotecan patient small cell lung cancer .</brief_summary>
	<brief_title>Study Relationship Between UGT1A1 Gene Polymorphism Toxicity Efficacy Irinotecan Small Cell Lung Cancer</brief_title>
	<detailed_description>In multiple study metastatic colorectal cancer , uridine diphosphate glucuronosyl transferase 1A1 ( UGT1A1 ) gene polymorphisms correlation irinotecan-associated side effect confirmed.Data several study indicate improved clinical outcome patient receive irinotecan-based regimen.In order find correlation UGT1A1 gene polymorphisms side effect efficacy irinotecan patient small cell lung cancer , design study .</detailed_description>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Small Cell</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Clinical diagnosis refractory relapse small cell lung cancer Physical examination routine laboratory test show contraindication chemotherapy Pregnant nursing woman Brain metastasis symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Irinotecan</keyword>
	<keyword>UGT1A1 Gene Polymorphisms</keyword>
	<keyword>Small Cell Carcinoma Lung</keyword>
</DOC>